Category Archives: Regions

Moment of truth for global TB response

On Thursday 16 November 2017, Russian president Vladimir Putin told a hall full of health ministers in Moscow that TB is a “serious problem”, and said, “I am confident that the only way we can stand up against this truly global threat … Continue reading

Posted in BRICS, R&D, Tuberculosis (TB), Uncategorized | Leave a comment

BRICS roots for affordable medicines

Public health targets should be placed above trade deals, says J.P. Nadda By Vidya Krishnan, The Hindu | December 17, 2016 Union Health Minister J.P. Nadda has pressed for public health targets to be placed above trade deals. “Trade regimes … Continue reading

Posted in BRICS, TRIPS plus, Uncategorized | Leave a comment

Open Letter to Ambassadors (in India) of RCEP negotiating countries by Delhi Network of Positive People

Open Letter to Ambassadors of RCEP negotiating countries  Member countries Must Consider the Impact of RCEP on Access to Medicines in Developing Countries  Don’t trade our lives away! We are writing to you on behalf of the Delhi Network of … Continue reading

Posted in Data Exclusivity, FTA, Investor state dispute, IPR Enforcement, LDC transition period, Regional Comprehensive Economic Partnership, TRIPS plus, UN General Assembly HLM | Leave a comment

GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries

Source: GSK Press Release, 31 March 2016 Adopts approach to intellectual property reflecting a country’s economic maturity Will not file for patent protection in Least Developed and Low Income Countries Will seek to grant licences to generic manufacturers to supply … Continue reading

Posted in IP Rights, LDCs, Medicine Patent Pool, Patent, Uncategorized | Leave a comment

Curing Hepatitis C, in an Experiment the Size of Egypt

The New York Times; December 16, 2015. SHABAS EL SHUHADA, Egypt — Abdel Gawad Ellabbad knows exactly how he was infected with hepatitis C. As a schoolboy in this Nile Delta rice-farming village, his class marched to the local clinic every month … Continue reading

Posted in Africa, Hepatitis C, Pricing, Sofosbuvir | Leave a comment

Speak up for affordable medicine

Iol news, Nobember 19, 2015. US and European pharmaceutical industries see South Africa as “ground zero” for keeping their large profit margins, say Julia Hill and Catherine Tomlinson. 

Posted in BRICS, Fix the patent law, Pricing, South Africa's Patent Act | Leave a comment

Tackling Antimicrobial Resistance Is an Area BRIC Countries Can Lead the World – They Must Take This Opportunity

Huffington Post; November 12, 2015. Brazil, India, Russia and China have gone through a period of rapid economic development, making them important global players in the 21st century. However, they are also the countries that might be affected most severely by growing antimicrobial … Continue reading

Posted in Antibiotics, BRICS, Innovation | Leave a comment